BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Results of Operations and Financial Condition

BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

Story continues below

On August 14, 2018, BioLargo, Inc. (“BioLargo”) issued a press release reporting its financial results for the second quarter ended June 30, 2018. A copy of the press release is attached hereto as Exhibit 99.1. The information in this Item 2.02 and the exhibit attached hereto are furnished to, but not filed with, the Securities and Exchange Commission.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No.

Description

99.1

Press Release dated August 14, 2018


BIOLARGO, INC. Exhibit
EX-99.1 2 ex_121745.htm EXHIBIT 99.1 ex_121745.htm Exhibit 99.1   BioLargo Achieves Record Product Sales and Revenues – Marching to First Industry-Wide Adoption   Westminster,…
To view the full exhibit click here

About BioLargo, Inc. (OTCMKTS:BLGO)

BioLargo, Inc. is a provider of platform technologies. The Company’s products are used to eliminate contaminants that threaten the water, health and quality of life. Its technology has commercial applications within several industries. The Company focuses on four areas: water treatment; industrial odor control applications; commercial, household and personal care products (CHAPP), and advanced wound care. Its AOS Filter combines iodine, water filter materials and electrolysis within a water filter device. It generates oxidation potential in order to oxidize and breakdown or otherwise eliminate, soluble organic contaminant, which are found in contaminated water. Its CupriDyne formula is used to deliver iodine within products. The Isan System is an automated iodine dosing system, which features controlled measuring, flow control, dosing and iodine extraction and removal technology, as well as an automatic tracking system that delivers iodine in calibrated doses.

An ad to help with our costs